Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Lynne D. Berry"'
Autor:
Shidan Wang, Ruichen Rong, Donghan M. Yang, Junya Fujimoto, Justin A. Bishop, Shirley Yan, Ling Cai, Carmen Behrens, Lynne D. Berry, Clare Wilhelm, Dara Aisner, Lynette Sholl, Bruce E. Johnson, David J. Kwiatkowski, Ignacio I. Wistuba, Paul A. Bunn Jr., John Minna, Guanghua Xiao, Mark G. Kris, Yang Xie
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 2 (2023)
Tyrosine kinase inhibitors (TKIs) targeting epidermal growth factor receptor (EGFR) are effective for many patients with lung cancer with EGFR mutations. However, not all patients are responsive to EGFR TKIs, including even those harboring EGFR-sensi
Externí odkaz:
https://doaj.org/article/4e4ef4f0039849eba1811dda587ccb82
Autor:
David J. Kwiatkowski, Paul A. Bunn, Mark G. Kris, John D. Minna, Bruce E. Johnson, Ignacio I. Wistuba, Kelly Kugler, Yu Shyr, Julie Brahmer, Lecia V. Sequist, Saiama N. Waqar, Joan Schiller, Edward B. Garon, Jeremy Cetnar, Bonnie Glisson, Katerina Politi, Eric Haura, Gregory A. Otterson, Liza C. Villaruz, Suresh S. Ramalingam, Andre L. Moreira, Junya Fujimoto, Heidi Chen, Michael R. Rossi, Lynne D. Berry, Lynette M. Sholl, Dara L. Aisner
Supplemental Table 7: Cases with two or more oncogenic driver alterations. Supplemental Table 8. Comparison of LCMC I and LCMC II.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::220c9bfb87c6e273b0091ae22c15ae02
https://doi.org/10.1158/1078-0432.22465377
https://doi.org/10.1158/1078-0432.22465377
Autor:
David J. Kwiatkowski, Paul A. Bunn, Mark G. Kris, John D. Minna, Bruce E. Johnson, Ignacio I. Wistuba, Kelly Kugler, Yu Shyr, Julie Brahmer, Lecia V. Sequist, Saiama N. Waqar, Joan Schiller, Edward B. Garon, Jeremy Cetnar, Bonnie Glisson, Katerina Politi, Eric Haura, Gregory A. Otterson, Liza C. Villaruz, Suresh S. Ramalingam, Andre L. Moreira, Junya Fujimoto, Heidi Chen, Michael R. Rossi, Lynne D. Berry, Lynette M. Sholl, Dara L. Aisner
Purpose: Multiplex genomic profiling is standard of care for patients with advanced lung adenocarcinomas. The Lung Cancer Mutation Consortium (LCMC) is a multi-institutional effort to identify and treat oncogenic driver events in patients with lung a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1913afb2e23158b562d64cb46a58133d
https://doi.org/10.1158/1078-0432.c.6526008
https://doi.org/10.1158/1078-0432.c.6526008
Autor:
David J. Kwiatkowski, Paul A. Bunn, Mark G. Kris, John D. Minna, Bruce E. Johnson, Ignacio I. Wistuba, Kelly Kugler, Yu Shyr, Julie Brahmer, Lecia V. Sequist, Saiama N. Waqar, Joan Schiller, Edward B. Garon, Jeremy Cetnar, Bonnie Glisson, Katerina Politi, Eric Haura, Gregory A. Otterson, Liza C. Villaruz, Suresh S. Ramalingam, Andre L. Moreira, Junya Fujimoto, Heidi Chen, Michael R. Rossi, Lynne D. Berry, Lynette M. Sholl, Dara L. Aisner
Supplemental Table 5. All subjects with all molecular results in LCMC2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::510d07c813f59adc1fe62d88707da624
https://doi.org/10.1158/1078-0432.22465386.v1
https://doi.org/10.1158/1078-0432.22465386.v1
Autor:
David J. Kwiatkowski, Paul A. Bunn, Mark G. Kris, John D. Minna, Bruce E. Johnson, Ignacio I. Wistuba, Kelly Kugler, Yu Shyr, Julie Brahmer, Lecia V. Sequist, Saiama N. Waqar, Joan Schiller, Edward B. Garon, Jeremy Cetnar, Bonnie Glisson, Katerina Politi, Eric Haura, Gregory A. Otterson, Liza C. Villaruz, Suresh S. Ramalingam, Andre L. Moreira, Junya Fujimoto, Heidi Chen, Michael R. Rossi, Lynne D. Berry, Lynette M. Sholl, Dara L. Aisner
PTEN and MET IHC methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ed2b0ba3a44a08ad88e28fba74a6786
https://doi.org/10.1158/1078-0432.22465389.v1
https://doi.org/10.1158/1078-0432.22465389.v1
Autor:
David J. Kwiatkowski, Paul A. Bunn, Mark G. Kris, John D. Minna, Bruce E. Johnson, Ignacio I. Wistuba, Kelly Kugler, Yu Shyr, Julie Brahmer, Lecia V. Sequist, Saiama N. Waqar, Joan Schiller, Edward B. Garon, Jeremy Cetnar, Bonnie Glisson, Katerina Politi, Eric Haura, Gregory A. Otterson, Liza C. Villaruz, Suresh S. Ramalingam, Andre L. Moreira, Junya Fujimoto, Heidi Chen, Michael R. Rossi, Lynne D. Berry, Lynette M. Sholl, Dara L. Aisner
Supplementary Figure 1 Sample Analysis Flowchart Supplementary Figure 2 LOMC2 Gene List Supplementary Figure 3 PTEN Immunohistochemistry analysis of LCMC II samples. Supplementary Figure 4 Mutation Frequency by Mutation and Smoking Status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9542dbd789701132715771c82d9941c6
https://doi.org/10.1158/1078-0432.22465392
https://doi.org/10.1158/1078-0432.22465392
Autor:
David O. Francis, Alexander Gelbard, Khodayar Goshtasbi, Sunil P. Verma, Catherine Anderson, Lynne D. Berry
Publikováno v:
Laryngoscope
OBJECTIVES To determine the factors that shape utilization of social media-based online support communities (OSCs) and study the influence of these communities on medical decision-making in patients with Idiopathic Subglottic Stenosis (iSGS). STUDY D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a27beb86f2577b436cff186f98a60c
https://doi.org/10.1002/lary.29110
https://doi.org/10.1002/lary.29110
Autor:
Madhusmita Behera, Dara L. Aisner, Lynne D. Berry, Suresh S. Ramalingam, Lynette M. Sholl, Badi El Osta, Sungjin Kim, Bruce E. Johnson, David J. Kwiatkowski, Fadlo R. Khuri, Rathi N. Pillai, Taofeek K. Owonikoko, Gabriel Sica, Mark G. Kris, Paul A. Bunn
Publikováno v:
J Thorac Oncol
Mutations in the KRAS gene are the most common driver oncogenes present in lung adenocarcinomas. We analyzed the largest multi-institutional database available containing patients with metastatic KRAS-mutant lung adenocarcinomas.The Lung Cancer Mutat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dedf9a12b1685a546df8860c9330fed
https://doi.org/10.1016/j.jtho.2019.01.020
https://doi.org/10.1016/j.jtho.2019.01.020
Autor:
Alex C. Cheng, Li Wen, Yanwei Li, Tatsuki Koyama, Lynne D. Berry, Tuya Pal, Debra L. Friedman, Travis John Osterman
Publikováno v:
Journal of Clinical Oncology. 40:e13568-e13568
e13568 Background: Crowdsourcing as a means of codifying the knowledge of many individuals can be an effective way to build models where data do not exist to inform these models. Risk for health complications during cancer survivorship is one area wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3954f7504410b47b6306efd58ffd7cc
https://doi.org/10.1200/jco.2022.40.16_suppl.e13568
https://doi.org/10.1200/jco.2022.40.16_suppl.e13568
Autor:
Boris Sepesi, David Randolph Jones, Bryan F. Meyers, Jamie E. Chaft, Lynette M. Sholl, Yu Shyr, Karen Kelly, Jules Lin, Paul A. Bunn, John D. Minna, Valerie W. Rusch, Ignacio Ivan Wistuba, David J. Kwiatkowski, David Paul Carbone, Lynne D. Berry, Jay M. Lee, Khaled Tolba, Mark G. Kris
Publikováno v:
Journal of Clinical Oncology. 40:TPS8596-TPS8596
TPS8596 Background: Comprehensive genomic profiling (CGP) has transformed the care of patients with advanced non-small cell lung cancer (NSCLC), giving many patients access to precision targeted treatment and immunotherapy with remarkable improvement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::348b4fd417296743ae9b6e7631ae168b
https://doi.org/10.1200/jco.2022.40.16_suppl.tps8596
https://doi.org/10.1200/jco.2022.40.16_suppl.tps8596